nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Vinblastine—head and neck cancer	0.258	0.537	CbGbCtD
Memantine—CYP2A6—Fluorouracil—head and neck cancer	0.222	0.463	CbGbCtD
Memantine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00137	0.00318	CcSEcCtD
Memantine—Influenza like illness—Docetaxel—head and neck cancer	0.00137	0.00318	CcSEcCtD
Memantine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00136	0.00316	CcSEcCtD
Memantine—Hallucination—Hydroxyurea—head and neck cancer	0.00136	0.00314	CcSEcCtD
Memantine—Colitis—Docetaxel—head and neck cancer	0.00135	0.00314	CcSEcCtD
Memantine—Irritability—Fluorouracil—head and neck cancer	0.00135	0.00314	CcSEcCtD
Memantine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00135	0.00313	CcSEcCtD
Memantine—Skin exfoliation—Docetaxel—head and neck cancer	0.00135	0.00312	CcSEcCtD
Memantine—Candida infection—Docetaxel—head and neck cancer	0.00135	0.00312	CcSEcCtD
Memantine—Ataxia—Fluorouracil—head and neck cancer	0.00133	0.00309	CcSEcCtD
Memantine—Neuropathy—Docetaxel—head and neck cancer	0.00132	0.00307	CcSEcCtD
Memantine—Alopecia—Vinblastine—head and neck cancer	0.00132	0.00306	CcSEcCtD
Memantine—Dry skin—Fluorouracil—head and neck cancer	0.0013	0.00301	CcSEcCtD
Memantine—Oesophagitis—Docetaxel—head and neck cancer	0.00129	0.00299	CcSEcCtD
Memantine—Neoplasm—Docetaxel—head and neck cancer	0.00128	0.00296	CcSEcCtD
Memantine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00127	0.00294	CcSEcCtD
Memantine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00126	0.00291	CcSEcCtD
Memantine—Muscular weakness—Fluorouracil—head and neck cancer	0.00125	0.0029	CcSEcCtD
Memantine—Angiopathy—Hydroxyurea—head and neck cancer	0.00124	0.00287	CcSEcCtD
Memantine—Dysphagia—Fluorouracil—head and neck cancer	0.00123	0.00284	CcSEcCtD
Memantine—Sepsis—Docetaxel—head and neck cancer	0.00122	0.00284	CcSEcCtD
Memantine—Chills—Hydroxyurea—head and neck cancer	0.00122	0.00284	CcSEcCtD
Memantine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00121	0.0028	CcSEcCtD
Memantine—Alopecia—Hydroxyurea—head and neck cancer	0.00121	0.00279	CcSEcCtD
Memantine—Anaemia—Vinblastine—head and neck cancer	0.0012	0.00279	CcSEcCtD
Memantine—Angina pectoris—Fluorouracil—head and neck cancer	0.00119	0.00277	CcSEcCtD
Memantine—Phlebitis—Docetaxel—head and neck cancer	0.00119	0.00275	CcSEcCtD
Memantine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00118	0.00274	CcSEcCtD
Memantine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00118	0.00273	CcSEcCtD
Memantine—Malaise—Vinblastine—head and neck cancer	0.00117	0.00272	CcSEcCtD
Memantine—Vertigo—Vinblastine—head and neck cancer	0.00117	0.00271	CcSEcCtD
Memantine—Leukopenia—Vinblastine—head and neck cancer	0.00117	0.0027	CcSEcCtD
Memantine—Pancytopenia—Fluorouracil—head and neck cancer	0.00116	0.0027	CcSEcCtD
Memantine—Deafness—Docetaxel—head and neck cancer	0.00114	0.00265	CcSEcCtD
Memantine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00114	0.00264	CcSEcCtD
Memantine—Hepatic failure—Docetaxel—head and neck cancer	0.00114	0.00264	CcSEcCtD
Memantine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00113	0.00262	CcSEcCtD
Memantine—Convulsion—Vinblastine—head and neck cancer	0.00113	0.00261	CcSEcCtD
Memantine—Hypertension—Vinblastine—head and neck cancer	0.00112	0.0026	CcSEcCtD
Memantine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0011	0.00255	CcSEcCtD
Memantine—Pneumonia—Fluorouracil—head and neck cancer	0.0011	0.00255	CcSEcCtD
Memantine—Anaemia—Hydroxyurea—head and neck cancer	0.0011	0.00254	CcSEcCtD
Memantine—Discomfort—Vinblastine—head and neck cancer	0.0011	0.00254	CcSEcCtD
Memantine—Hot flush—Docetaxel—head and neck cancer	0.00109	0.00254	CcSEcCtD
Memantine—Infestation—Fluorouracil—head and neck cancer	0.00109	0.00253	CcSEcCtD
Memantine—Infestation NOS—Fluorouracil—head and neck cancer	0.00109	0.00253	CcSEcCtD
Memantine—Menopausal symptoms—Docetaxel—head and neck cancer	0.00109	0.00252	CcSEcCtD
Memantine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00108	0.0025	CcSEcCtD
Memantine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00108	0.0025	CcSEcCtD
Memantine—Renal impairment—Docetaxel—head and neck cancer	0.00108	0.00249	CcSEcCtD
Memantine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00107	0.00248	CcSEcCtD
Memantine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00107	0.00248	CcSEcCtD
Memantine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00107	0.00248	CcSEcCtD
Memantine—Malaise—Hydroxyurea—head and neck cancer	0.00107	0.00248	CcSEcCtD
Memantine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00106	0.00246	CcSEcCtD
Memantine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00106	0.00246	CcSEcCtD
Memantine—Leukopenia—Hydroxyurea—head and neck cancer	0.00106	0.00246	CcSEcCtD
Memantine—Cardiac failure—Docetaxel—head and neck cancer	0.00105	0.00243	CcSEcCtD
Memantine—Lethargy—Docetaxel—head and neck cancer	0.00105	0.00242	CcSEcCtD
Memantine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00104	0.00241	CcSEcCtD
Memantine—Epistaxis—Fluorouracil—head and neck cancer	0.00103	0.00239	CcSEcCtD
Memantine—Convulsion—Hydroxyurea—head and neck cancer	0.00103	0.00238	CcSEcCtD
Memantine—Hyponatraemia—Docetaxel—head and neck cancer	0.00103	0.00238	CcSEcCtD
Memantine—Sinusitis—Fluorouracil—head and neck cancer	0.00103	0.00238	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00102	0.00237	CcSEcCtD
Memantine—Pain in extremity—Docetaxel—head and neck cancer	0.00102	0.00237	CcSEcCtD
Memantine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00102	0.00236	CcSEcCtD
Memantine—Anorexia—Vinblastine—head and neck cancer	0.00101	0.00235	CcSEcCtD
Memantine—Discomfort—Hydroxyurea—head and neck cancer	0.000999	0.00231	CcSEcCtD
Memantine—Haemoglobin—Fluorouracil—head and neck cancer	0.000987	0.00229	CcSEcCtD
Memantine—Rhinitis—Fluorouracil—head and neck cancer	0.000984	0.00228	CcSEcCtD
Memantine—GRIN2A—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.000984	0.011	CbGpPWpGaD
Memantine—Haemorrhage—Fluorouracil—head and neck cancer	0.000982	0.00227	CcSEcCtD
Memantine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000977	0.00226	CcSEcCtD
Memantine—Pharyngitis—Fluorouracil—head and neck cancer	0.000974	0.00226	CcSEcCtD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—head and neck cancer	0.00097	0.0109	CbGpPWpGaD
Memantine—Oedema—Hydroxyurea—head and neck cancer	0.000969	0.00225	CcSEcCtD
Memantine—Ataxia—Docetaxel—head and neck cancer	0.000963	0.00223	CcSEcCtD
Memantine—Infection—Hydroxyurea—head and neck cancer	0.000963	0.00223	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000962	0.0108	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000957	0.0107	CbGpPWpGaD
Memantine—Paraesthesia—Vinblastine—head and neck cancer	0.000954	0.00221	CcSEcCtD
Memantine—Dehydration—Docetaxel—head and neck cancer	0.000953	0.00221	CcSEcCtD
Memantine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00095	0.0022	CcSEcCtD
Memantine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000949	0.0022	CcSEcCtD
Memantine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000946	0.00219	CcSEcCtD
Memantine—Skin disorder—Hydroxyurea—head and neck cancer	0.000941	0.00218	CcSEcCtD
Memantine—Dry skin—Docetaxel—head and neck cancer	0.000939	0.00218	CcSEcCtD
Memantine—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.000936	0.0105	CbGpPWpGaD
Memantine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000935	0.00217	CcSEcCtD
Memantine—Anorexia—Hydroxyurea—head and neck cancer	0.000924	0.00214	CcSEcCtD
Memantine—Decreased appetite—Vinblastine—head and neck cancer	0.000924	0.00214	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000922	0.00214	CcSEcCtD
Memantine—Nasopharyngitis—Docetaxel—head and neck cancer	0.000916	0.00212	CcSEcCtD
Memantine—Constipation—Vinblastine—head and neck cancer	0.000909	0.00211	CcSEcCtD
Memantine—Pain—Vinblastine—head and neck cancer	0.000909	0.00211	CcSEcCtD
Memantine—GRIN2A—Reelin signaling pathway—PIK3CA—head and neck cancer	0.000904	0.0101	CbGpPWpGaD
Memantine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000903	0.00209	CcSEcCtD
Memantine—Dysphagia—Docetaxel—head and neck cancer	0.000885	0.00205	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—MAPK1—head and neck cancer	0.000884	0.00992	CbGpPWpGaD
Memantine—Arrhythmia—Fluorouracil—head and neck cancer	0.000877	0.00203	CcSEcCtD
Memantine—Feeling abnormal—Vinblastine—head and neck cancer	0.000876	0.00203	CcSEcCtD
Memantine—Bronchospasm—Docetaxel—head and neck cancer	0.000871	0.00202	CcSEcCtD
Memantine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000869	0.00201	CcSEcCtD
Memantine—Alopecia—Fluorouracil—head and neck cancer	0.000868	0.00201	CcSEcCtD
Memantine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000864	0.002	CcSEcCtD
Memantine—Angina pectoris—Docetaxel—head and neck cancer	0.000862	0.002	CcSEcCtD
Memantine—Somnolence—Hydroxyurea—head and neck cancer	0.000861	0.002	CcSEcCtD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—MAPK1—head and neck cancer	0.000861	0.00967	CbGpPWpGaD
Memantine—GRIN1—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.000858	0.00963	CbGpPWpGaD
Memantine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000853	0.00198	CcSEcCtD
Memantine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000842	0.00195	CcSEcCtD
Memantine—Pancytopenia—Docetaxel—head and neck cancer	0.000841	0.00195	CcSEcCtD
Memantine—Abdominal pain—Vinblastine—head and neck cancer	0.00084	0.00195	CcSEcCtD
Memantine—GRIN2B—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.000837	0.00939	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000837	0.00194	CcSEcCtD
Memantine—Fatigue—Hydroxyurea—head and neck cancer	0.000835	0.00194	CcSEcCtD
Memantine—GRIN2A—Post NMDA receptor activation events—MAPK1—head and neck cancer	0.000834	0.00936	CbGpPWpGaD
Memantine—Constipation—Hydroxyurea—head and neck cancer	0.000829	0.00192	CcSEcCtD
Memantine—Pain—Hydroxyurea—head and neck cancer	0.000829	0.00192	CcSEcCtD
Memantine—Neutropenia—Docetaxel—head and neck cancer	0.000828	0.00192	CcSEcCtD
Memantine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000821	0.00921	CbGpPWpGaD
Memantine—GRIN1—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.000817	0.00917	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—head and neck cancer	0.000813	0.00913	CbGpPWpGaD
Memantine—Weight increased—Docetaxel—head and neck cancer	0.000806	0.00187	CcSEcCtD
Memantine—Vision blurred—Fluorouracil—head and neck cancer	0.000805	0.00187	CcSEcCtD
Memantine—Weight decreased—Docetaxel—head and neck cancer	0.000801	0.00186	CcSEcCtD
Memantine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000799	0.00185	CcSEcCtD
Memantine—GRIN2B—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.000796	0.00893	CbGpPWpGaD
Memantine—Pneumonia—Docetaxel—head and neck cancer	0.000794	0.00184	CcSEcCtD
Memantine—Anaemia—Fluorouracil—head and neck cancer	0.00079	0.00183	CcSEcCtD
Memantine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000789	0.00886	CbGpPWpGaD
Memantine—Infestation NOS—Docetaxel—head and neck cancer	0.000789	0.00183	CcSEcCtD
Memantine—Infestation—Docetaxel—head and neck cancer	0.000789	0.00183	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—CASP8—head and neck cancer	0.000786	0.00882	CbGpPWpGaD
Memantine—Hypersensitivity—Vinblastine—head and neck cancer	0.000783	0.00181	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000783	0.00181	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—MAPK3—head and neck cancer	0.000779	0.00874	CbGpPWpGaD
Memantine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000778	0.0018	CcSEcCtD
Memantine—Renal failure—Docetaxel—head and neck cancer	0.000776	0.0018	CcSEcCtD
Memantine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000774	0.00179	CcSEcCtD
Memantine—Myocardial infarction—Docetaxel—head and neck cancer	0.000774	0.00179	CcSEcCtD
Memantine—GRIN2B—Reelin signaling pathway—PIK3CA—head and neck cancer	0.000769	0.00863	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—head and neck cancer	0.000768	0.00862	CbGpPWpGaD
Memantine—Conjunctivitis—Docetaxel—head and neck cancer	0.000767	0.00178	CcSEcCtD
Memantine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000766	0.00178	CcSEcCtD
Memantine—Leukopenia—Fluorouracil—head and neck cancer	0.000765	0.00177	CcSEcCtD
Memantine—Asthenia—Vinblastine—head and neck cancer	0.000762	0.00177	CcSEcCtD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000754	0.00846	CbGpPWpGaD
Memantine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000746	0.00173	CcSEcCtD
Memantine—Epistaxis—Docetaxel—head and neck cancer	0.000744	0.00173	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—MAPK1—head and neck cancer	0.000741	0.00832	CbGpPWpGaD
Memantine—Convulsion—Fluorouracil—head and neck cancer	0.00074	0.00172	CcSEcCtD
Memantine—GRIN2A—Reelin signaling pathway—AKT1—head and neck cancer	0.000738	0.00829	CbGpPWpGaD
Memantine—Agranulocytosis—Docetaxel—head and neck cancer	0.000737	0.00171	CcSEcCtD
Memantine—Myalgia—Fluorouracil—head and neck cancer	0.000728	0.00169	CcSEcCtD
Memantine—Chest pain—Fluorouracil—head and neck cancer	0.000728	0.00169	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—MAPK1—head and neck cancer	0.000727	0.00816	CbGpPWpGaD
Memantine—Diarrhoea—Vinblastine—head and neck cancer	0.000727	0.00168	CcSEcCtD
Memantine—Discomfort—Fluorouracil—head and neck cancer	0.000719	0.00167	CcSEcCtD
Memantine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000714	0.00165	CcSEcCtD
Memantine—Haemoglobin—Docetaxel—head and neck cancer	0.000712	0.00165	CcSEcCtD
Memantine—Rhinitis—Docetaxel—head and neck cancer	0.00071	0.00165	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—head and neck cancer	0.000709	0.00796	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—MAPK1—head and neck cancer	0.000709	0.00796	CbGpPWpGaD
Memantine—Hepatitis—Docetaxel—head and neck cancer	0.000709	0.00164	CcSEcCtD
Memantine—Haemorrhage—Docetaxel—head and neck cancer	0.000709	0.00164	CcSEcCtD
Memantine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000705	0.00163	CcSEcCtD
Memantine—Confusional state—Fluorouracil—head and neck cancer	0.000703	0.00163	CcSEcCtD
Memantine—Pharyngitis—Docetaxel—head and neck cancer	0.000703	0.00163	CcSEcCtD
Memantine—Dizziness—Vinblastine—head and neck cancer	0.000703	0.00163	CcSEcCtD
Memantine—Urinary tract disorder—Docetaxel—head and neck cancer	0.0007	0.00162	CcSEcCtD
Memantine—Oedema peripheral—Docetaxel—head and neck cancer	0.000698	0.00162	CcSEcCtD
Memantine—Oedema—Fluorouracil—head and neck cancer	0.000697	0.00162	CcSEcCtD
Memantine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000696	0.00161	CcSEcCtD
Memantine—Asthenia—Hydroxyurea—head and neck cancer	0.000695	0.00161	CcSEcCtD
Memantine—Urethral disorder—Docetaxel—head and neck cancer	0.000695	0.00161	CcSEcCtD
Memantine—Infection—Fluorouracil—head and neck cancer	0.000693	0.00161	CcSEcCtD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—head and neck cancer	0.000691	0.00776	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—CASP8—head and neck cancer	0.000686	0.0077	CbGpPWpGaD
Memantine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000684	0.00158	CcSEcCtD
Memantine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000683	0.00158	CcSEcCtD
Memantine—Visual impairment—Docetaxel—head and neck cancer	0.000683	0.00158	CcSEcCtD
Memantine—Tachycardia—Fluorouracil—head and neck cancer	0.000681	0.00158	CcSEcCtD
Memantine—Vomiting—Vinblastine—head and neck cancer	0.000676	0.00157	CcSEcCtD
Memantine—Erythema multiforme—Docetaxel—head and neck cancer	0.00067	0.00155	CcSEcCtD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—head and neck cancer	0.00067	0.00752	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—head and neck cancer	0.000669	0.00751	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—CASP8—head and neck cancer	0.000668	0.0075	CbGpPWpGaD
Memantine—Headache—Vinblastine—head and neck cancer	0.000666	0.00154	CcSEcCtD
Memantine—Anorexia—Fluorouracil—head and neck cancer	0.000665	0.00154	CcSEcCtD
Memantine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000663	0.00154	CcSEcCtD
Memantine—Eye disorder—Docetaxel—head and neck cancer	0.000662	0.00153	CcSEcCtD
Memantine—Flushing—Docetaxel—head and neck cancer	0.000658	0.00152	CcSEcCtD
Memantine—Cardiac disorder—Docetaxel—head and neck cancer	0.000658	0.00152	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—head and neck cancer	0.000653	0.00733	CbGpPWpGaD
Memantine—Hypotension—Fluorouracil—head and neck cancer	0.000652	0.00151	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—PIK3CA—head and neck cancer	0.000643	0.00722	CbGpPWpGaD
Memantine—Angiopathy—Docetaxel—head and neck cancer	0.000643	0.00149	CcSEcCtD
Memantine—Dizziness—Hydroxyurea—head and neck cancer	0.000641	0.00148	CcSEcCtD
Memantine—Immune system disorder—Docetaxel—head and neck cancer	0.00064	0.00148	CcSEcCtD
Memantine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000639	0.00148	CcSEcCtD
Memantine—Chills—Docetaxel—head and neck cancer	0.000636	0.00147	CcSEcCtD
Memantine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000635	0.00147	CcSEcCtD
Memantine—Arrhythmia—Docetaxel—head and neck cancer	0.000633	0.00147	CcSEcCtD
Memantine—Nausea—Vinblastine—head and neck cancer	0.000631	0.00146	CcSEcCtD
Memantine—Insomnia—Fluorouracil—head and neck cancer	0.000631	0.00146	CcSEcCtD
Memantine—GRIN2B—Reelin signaling pathway—AKT1—head and neck cancer	0.000628	0.00705	CbGpPWpGaD
Memantine—Paraesthesia—Fluorouracil—head and neck cancer	0.000626	0.00145	CcSEcCtD
Memantine—Alopecia—Docetaxel—head and neck cancer	0.000626	0.00145	CcSEcCtD
Memantine—Dyspnoea—Fluorouracil—head and neck cancer	0.000622	0.00144	CcSEcCtD
Memantine—Mental disorder—Docetaxel—head and neck cancer	0.000621	0.00144	CcSEcCtD
Memantine—Somnolence—Fluorouracil—head and neck cancer	0.00062	0.00144	CcSEcCtD
Memantine—Malnutrition—Docetaxel—head and neck cancer	0.000617	0.00143	CcSEcCtD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—head and neck cancer	0.000616	0.00692	CbGpPWpGaD
Memantine—Vomiting—Hydroxyurea—head and neck cancer	0.000616	0.00143	CcSEcCtD
Memantine—Dyspepsia—Fluorouracil—head and neck cancer	0.000614	0.00142	CcSEcCtD
Memantine—Rash—Hydroxyurea—head and neck cancer	0.000611	0.00142	CcSEcCtD
Memantine—Dermatitis—Hydroxyurea—head and neck cancer	0.00061	0.00141	CcSEcCtD
Memantine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00061	0.00684	CbGpPWpGaD
Memantine—Headache—Hydroxyurea—head and neck cancer	0.000607	0.00141	CcSEcCtD
Memantine—Decreased appetite—Fluorouracil—head and neck cancer	0.000606	0.0014	CcSEcCtD
Memantine—Dysgeusia—Docetaxel—head and neck cancer	0.000604	0.0014	CcSEcCtD
Memantine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000602	0.0014	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000598	0.00671	CbGpPWpGaD
Memantine—Back pain—Docetaxel—head and neck cancer	0.000597	0.00138	CcSEcCtD
Memantine—Pain—Fluorouracil—head and neck cancer	0.000596	0.00138	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—head and neck cancer	0.000584	0.00655	CbGpPWpGaD
Memantine—Nausea—Hydroxyurea—head and neck cancer	0.000576	0.00133	CcSEcCtD
Memantine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000575	0.00133	CcSEcCtD
Memantine—Anaemia—Docetaxel—head and neck cancer	0.00057	0.00132	CcSEcCtD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—head and neck cancer	0.000569	0.00639	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000559	0.00627	CbGpPWpGaD
Memantine—Urticaria—Fluorouracil—head and neck cancer	0.000554	0.00128	CcSEcCtD
Memantine—Syncope—Docetaxel—head and neck cancer	0.000553	0.00128	CcSEcCtD
Memantine—Leukopenia—Docetaxel—head and neck cancer	0.000552	0.00128	CcSEcCtD
Memantine—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000552	0.00619	CbGpPWpGaD
Memantine—Body temperature increased—Fluorouracil—head and neck cancer	0.000551	0.00128	CcSEcCtD
Memantine—Palpitations—Docetaxel—head and neck cancer	0.000545	0.00126	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CEBPA—head and neck cancer	0.000545	0.00611	CbGpPWpGaD
Memantine—Loss of consciousness—Docetaxel—head and neck cancer	0.000542	0.00126	CcSEcCtD
Memantine—Cough—Docetaxel—head and neck cancer	0.000538	0.00125	CcSEcCtD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—head and neck cancer	0.000538	0.00603	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—head and neck cancer	0.000538	0.00603	CbGpPWpGaD
Memantine—Convulsion—Docetaxel—head and neck cancer	0.000534	0.00124	CcSEcCtD
Memantine—Hypertension—Docetaxel—head and neck cancer	0.000533	0.00123	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—CEBPA—head and neck cancer	0.000531	0.00596	CbGpPWpGaD
Memantine—Myalgia—Docetaxel—head and neck cancer	0.000525	0.00122	CcSEcCtD
Memantine—Arthralgia—Docetaxel—head and neck cancer	0.000525	0.00122	CcSEcCtD
Memantine—Chest pain—Docetaxel—head and neck cancer	0.000525	0.00122	CcSEcCtD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—head and neck cancer	0.000524	0.00588	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—head and neck cancer	0.000524	0.00588	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000514	0.00577	CbGpPWpGaD
Memantine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000514	0.00119	CcSEcCtD
Memantine—Dry mouth—Docetaxel—head and neck cancer	0.000514	0.00119	CcSEcCtD
Memantine—Confusional state—Docetaxel—head and neck cancer	0.000508	0.00118	CcSEcCtD
Memantine—Oedema—Docetaxel—head and neck cancer	0.000503	0.00117	CcSEcCtD
Memantine—Infection—Docetaxel—head and neck cancer	0.0005	0.00116	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000498	0.00559	CbGpPWpGaD
Memantine—Shock—Docetaxel—head and neck cancer	0.000495	0.00115	CcSEcCtD
Memantine—Nervous system disorder—Docetaxel—head and neck cancer	0.000494	0.00114	CcSEcCtD
Memantine—Pruritus—Fluorouracil—head and neck cancer	0.000493	0.00114	CcSEcCtD
Memantine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000493	0.00114	CcSEcCtD
Memantine—Tachycardia—Docetaxel—head and neck cancer	0.000491	0.00114	CcSEcCtD
Memantine—Skin disorder—Docetaxel—head and neck cancer	0.000489	0.00113	CcSEcCtD
Memantine—Anorexia—Docetaxel—head and neck cancer	0.00048	0.00111	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—MAPK3—head and neck cancer	0.000478	0.00536	CbGpPWpGaD
Memantine—Diarrhoea—Fluorouracil—head and neck cancer	0.000477	0.00111	CcSEcCtD
Memantine—Hypotension—Docetaxel—head and neck cancer	0.00047	0.00109	CcSEcCtD
Memantine—Dizziness—Fluorouracil—head and neck cancer	0.000461	0.00107	CcSEcCtD
Memantine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000459	0.00106	CcSEcCtD
Memantine—Insomnia—Docetaxel—head and neck cancer	0.000455	0.00106	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—MAPK1—head and neck cancer	0.000454	0.0051	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000453	0.00509	CbGpPWpGaD
Memantine—Paraesthesia—Docetaxel—head and neck cancer	0.000452	0.00105	CcSEcCtD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000451	0.00506	CbGpPWpGaD
Memantine—Dyspnoea—Docetaxel—head and neck cancer	0.000449	0.00104	CcSEcCtD
Memantine—Somnolence—Docetaxel—head and neck cancer	0.000448	0.00104	CcSEcCtD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000445	0.005	CbGpPWpGaD
Memantine—Vomiting—Fluorouracil—head and neck cancer	0.000443	0.00103	CcSEcCtD
Memantine—Dyspepsia—Docetaxel—head and neck cancer	0.000443	0.00103	CcSEcCtD
Memantine—Rash—Fluorouracil—head and neck cancer	0.00044	0.00102	CcSEcCtD
Memantine—Dermatitis—Fluorouracil—head and neck cancer	0.000439	0.00102	CcSEcCtD
Memantine—Decreased appetite—Docetaxel—head and neck cancer	0.000438	0.00101	CcSEcCtD
Memantine—Headache—Fluorouracil—head and neck cancer	0.000437	0.00101	CcSEcCtD
Memantine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000435	0.00101	CcSEcCtD
Memantine—Fatigue—Docetaxel—head and neck cancer	0.000434	0.00101	CcSEcCtD
Memantine—Pain—Docetaxel—head and neck cancer	0.00043	0.000998	CcSEcCtD
Memantine—Constipation—Docetaxel—head and neck cancer	0.00043	0.000998	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—MAPK3—head and neck cancer	0.000417	0.00467	CbGpPWpGaD
Memantine—Feeling abnormal—Docetaxel—head and neck cancer	0.000415	0.000961	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000415	0.00466	CbGpPWpGaD
Memantine—Nausea—Fluorouracil—head and neck cancer	0.000414	0.00096	CcSEcCtD
Memantine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000412	0.000954	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000409	0.00459	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—MAPK3—head and neck cancer	0.000406	0.00456	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—head and neck cancer	0.000405	0.00455	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000398	0.00447	CbGpPWpGaD
Memantine—Body temperature increased—Docetaxel—head and neck cancer	0.000398	0.000922	CcSEcCtD
Memantine—Abdominal pain—Docetaxel—head and neck cancer	0.000398	0.000922	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—MAPK1—head and neck cancer	0.000396	0.00445	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000394	0.00443	CbGpPWpGaD
Memantine—DRD2—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.000394	0.00442	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—MAPK1—head and neck cancer	0.000386	0.00434	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—head and neck cancer	0.000383	0.0043	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—head and neck cancer	0.000381	0.00428	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL2—head and neck cancer	0.000376	0.00422	CbGpPWpGaD
Memantine—DRD2—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.000375	0.00421	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—head and neck cancer	0.000373	0.00419	CbGpPWpGaD
Memantine—Hypersensitivity—Docetaxel—head and neck cancer	0.000371	0.000859	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—CCND1—head and neck cancer	0.000366	0.00411	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000366	0.0041	CbGpPWpGaD
Memantine—Asthenia—Docetaxel—head and neck cancer	0.000361	0.000837	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00036	0.00404	CbGpPWpGaD
Memantine—Pruritus—Docetaxel—head and neck cancer	0.000356	0.000825	CcSEcCtD
Memantine—Diarrhoea—Docetaxel—head and neck cancer	0.000344	0.000798	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000341	0.00383	CbGpPWpGaD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000336	0.00378	CbGpPWpGaD
Memantine—Dizziness—Docetaxel—head and neck cancer	0.000333	0.000771	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—head and neck cancer	0.000333	0.00373	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—head and neck cancer	0.000324	0.00364	CbGpPWpGaD
Memantine—Vomiting—Docetaxel—head and neck cancer	0.00032	0.000742	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000319	0.00358	CbGpPWpGaD
Memantine—Rash—Docetaxel—head and neck cancer	0.000317	0.000736	CcSEcCtD
Memantine—Dermatitis—Docetaxel—head and neck cancer	0.000317	0.000735	CcSEcCtD
Memantine—Headache—Docetaxel—head and neck cancer	0.000315	0.000731	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000313	0.00352	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000309	0.00347	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000307	0.00345	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MAPK3—head and neck cancer	0.000302	0.00339	CbGpPWpGaD
Memantine—Nausea—Docetaxel—head and neck cancer	0.000299	0.000693	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000297	0.00333	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.00029	0.00325	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MAPK1—head and neck cancer	0.000287	0.00323	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000287	0.00323	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—head and neck cancer	0.000287	0.00323	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—head and neck cancer	0.000277	0.00311	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000276	0.0031	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—KISS1—head and neck cancer	0.000274	0.00308	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—head and neck cancer	0.00027	0.00303	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—STAT3—head and neck cancer	0.00027	0.00303	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—STAT3—head and neck cancer	0.000263	0.00295	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000259	0.0029	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—MAPK3—head and neck cancer	0.000258	0.00289	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000255	0.00287	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000254	0.00285	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—MAPK3—head and neck cancer	0.000251	0.00282	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000251	0.00281	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—MAPK1—head and neck cancer	0.000245	0.00275	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000244	0.00274	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—head and neck cancer	0.000241	0.00271	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000241	0.0027	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—MAPK1—head and neck cancer	0.000239	0.00268	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000235	0.00263	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000231	0.00259	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—UROD—head and neck cancer	0.000231	0.00259	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GRP—head and neck cancer	0.000226	0.00253	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TYMS—head and neck cancer	0.000218	0.00245	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000216	0.00243	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—UROD—head and neck cancer	0.000212	0.00238	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000205	0.0023	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000202	0.00227	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000201	0.00226	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—HRAS—head and neck cancer	0.000197	0.00221	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000196	0.0022	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000194	0.00218	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—head and neck cancer	0.000192	0.00215	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000192	0.00215	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000188	0.00212	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000184	0.00206	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—AKT1—head and neck cancer	0.000174	0.00195	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NOTCH1—head and neck cancer	0.000174	0.00195	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000173	0.00195	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—UROD—head and neck cancer	0.000171	0.00192	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—head and neck cancer	0.000169	0.0019	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NOTCH1—head and neck cancer	0.000169	0.0019	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—MAPK1—head and neck cancer	0.000166	0.00186	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—KISS1—head and neck cancer	0.000155	0.00174	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000155	0.00174	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000153	0.00171	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000151	0.0017	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000148	0.00166	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000147	0.00165	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000145	0.00162	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—MAPK1—head and neck cancer	0.000144	0.00162	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—head and neck cancer	0.000142	0.0016	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—MAPK1—head and neck cancer	0.000141	0.00158	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KISS1—head and neck cancer	0.000141	0.00158	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—head and neck cancer	0.000139	0.00156	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK3—head and neck cancer	0.000135	0.00151	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—head and neck cancer	0.000133	0.00149	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MAPK3—head and neck cancer	0.000131	0.00147	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—UROD—head and neck cancer	0.000129	0.00145	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK1—head and neck cancer	0.000128	0.00144	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—head and neck cancer	0.000128	0.00144	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GRP—head and neck cancer	0.000128	0.00143	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MAPK1—head and neck cancer	0.000125	0.0014	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—head and neck cancer	0.000125	0.0014	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—head and neck cancer	0.000116	0.0013	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GRP—head and neck cancer	0.000116	0.0013	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—head and neck cancer	0.000113	0.00127	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—head and neck cancer	0.000106	0.00119	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—head and neck cancer	0.000103	0.00115	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—head and neck cancer	0.000102	0.00114	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—head and neck cancer	0.000101	0.00113	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—head and neck cancer	0.0001	0.00113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0001	0.00112	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—head and neck cancer	9.9e-05	0.00111	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—head and neck cancer	9.81e-05	0.0011	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	9.8e-05	0.0011	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MAPK3—head and neck cancer	9.61e-05	0.00108	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NAT2—head and neck cancer	9.58e-05	0.00108	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK3—head and neck cancer	9.37e-05	0.00105	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MAPK1—head and neck cancer	9.14e-05	0.00103	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—head and neck cancer	9.14e-05	0.00103	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK1—head and neck cancer	8.91e-05	0.001	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—head and neck cancer	8.91e-05	0.001	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NAT2—head and neck cancer	8.79e-05	0.000987	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—DPYD—head and neck cancer	8.4e-05	0.000943	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KISS1—head and neck cancer	8.31e-05	0.000933	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—YAP1—head and neck cancer	7.97e-05	0.000895	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	7.87e-05	0.000883	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—DPYD—head and neck cancer	7.71e-05	0.000865	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MAPK1—head and neck cancer	7.51e-05	0.000843	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—head and neck cancer	7.34e-05	0.000824	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—YAP1—head and neck cancer	7.32e-05	0.000821	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—head and neck cancer	7.23e-05	0.000812	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—head and neck cancer	7.16e-05	0.000803	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NAT2—head and neck cancer	7.09e-05	0.000796	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRP—head and neck cancer	6.85e-05	0.000768	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT6—head and neck cancer	6.65e-05	0.000746	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—head and neck cancer	6.48e-05	0.000728	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—head and neck cancer	6.32e-05	0.000709	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—DPYD—head and neck cancer	6.22e-05	0.000698	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—head and neck cancer	6.03e-05	0.000677	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—YAP1—head and neck cancer	5.9e-05	0.000663	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—YAP1—head and neck cancer	5.88e-05	0.00066	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.69e-05	0.000639	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.64e-05	0.000633	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAT2—head and neck cancer	5.36e-05	0.000602	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—head and neck cancer	4.79e-05	0.000537	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—head and neck cancer	4.73e-05	0.000531	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—DPYD—head and neck cancer	4.7e-05	0.000528	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—head and neck cancer	4.53e-05	0.000508	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A1—head and neck cancer	4.48e-05	0.000503	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—YAP1—head and neck cancer	4.46e-05	0.000501	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—head and neck cancer	4.39e-05	0.000493	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—head and neck cancer	4.34e-05	0.000487	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—head and neck cancer	4.16e-05	0.000467	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A1—head and neck cancer	4.12e-05	0.000462	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—head and neck cancer	3.54e-05	0.000398	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—head and neck cancer	3.5e-05	0.000393	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—head and neck cancer	3.4e-05	0.000382	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—head and neck cancer	3.36e-05	0.000377	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.35e-05	0.000376	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	3.32e-05	0.000373	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—head and neck cancer	3.09e-05	0.000347	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.92e-05	0.000328	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.68e-05	0.000301	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—head and neck cancer	2.67e-05	0.000299	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	2.65e-05	0.000298	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.65e-05	0.000297	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—head and neck cancer	2.54e-05	0.000285	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.51e-05	0.000282	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	2.48e-05	0.000279	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.45e-05	0.000275	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	2.36e-05	0.000265	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	2.36e-05	0.000265	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—head and neck cancer	2.33e-05	0.000261	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	2.26e-05	0.000253	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—head and neck cancer	2.14e-05	0.00024	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.06e-05	0.000231	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	2.05e-05	0.00023	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.98e-05	0.000222	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.9e-05	0.000213	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.84e-05	0.000207	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—head and neck cancer	1.82e-05	0.000205	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.78e-05	0.0002	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—head and neck cancer	1.72e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.72e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.67e-05	0.000188	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	1.64e-05	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.55e-05	0.000174	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.53e-05	0.000172	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.51e-05	0.000169	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.49e-05	0.000168	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.47e-05	0.000165	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.4e-05	0.000157	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.4e-05	0.000157	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—head and neck cancer	1.34e-05	0.00015	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.3e-05	0.000146	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—head and neck cancer	1.23e-05	0.000138	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.22e-05	0.000136	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.21e-05	0.000136	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.17e-05	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.12e-05	0.000126	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—head and neck cancer	9.93e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—head and neck cancer	9.89e-06	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	9.18e-06	0.000103	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—head and neck cancer	7.5e-06	8.42e-05	CbGpPWpGaD
